CD19 and bacterial infectious disease: Moreover, antimicrobial prophylaxis including levofloxacin for gram-negative bacteria in patients with neutropenia can be beneficial in the prevention of bacterial infections in patients receiving CD19-redirected CAR-T therapy (25, 164, 165).